EGM COVID-19 Mitigation Measures

RNS Number : 0404M
Origin Enterprises Plc
18 January 2021
 

  IMPORTANT NOTICE

 

Measures to mitigate Coronavirus (COVID-19) transmission at the Origin Enterprises plc

Extraordinary General Meeting to be held - under constrained circumstances due to COVID-19 -

on Thursday, 28 January 2021 at 10:30 a.m.

at Origin Enterprises plc, 4-6 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

 

 

 

EGM

The purpose of the Extraordinary General Meeting (EGM) on 28 January 2021 is to seek approval of certain resolutions relating to the replacement of the CREST system with a system operated by Euroclear Bank for the electronic settlement of trading in the Company's shares. Further details are set out in the Notice of EGM, published on 24 December 2020 and available on our website at https://originenterprises.com .

 

COVID-19 Restrictions

The Company considers the well-being of shareholders, employees and other stakeholders a top priority and will conduct the EGM in accordance with the Irish Government's COVID-19 related public health measures and public health advice, aimed at reducing the transmission of COVID-19.

 

As a result of the latest measures put in place by the Government under the 'Framework for Restrictive Measures', shareholders should expect the EGM to take place under constrained circumstances. In particular, the Board is advising that the EGM will now be held effectively as a closed meeting, as the Company will not be in a position to allow physical attendance for shareholders. The Company will ensure that all legal requirements of the meeting, in accordance with its Articles of Association, are satisfied with the minimum necessary quorum of three shareholders which will be facilitated by the Company.

 

Shareholder Participation

While personal attendance by shareholders will not be permissible, the Company recognises the importance of continuing engagement in the lead up to the EGM.

 

We encourage all shareholders to vote by proxy in advance of the EGM as described in the published Notice of EGM (available on our website, together with a Form of Proxy). Proxies must be received by no later than 10.30 a.m. on Tuesday, 26 January 2021.

 

Shareholders can submit questions for the Board in advance of the meeting by emailing the Company at EGM2021@originenterprises.com , stating your name and Investor Code (as printed on your share certificate or obtained through the Company's Registrar, Link Registrars Limited). Questions are to be submitted by no later than 10.30 a.m. on Tuesday, 26 January 2021.  

 

Conference Call Facility

In order to facilitate shareholders to listen to the proceedings of the meeting, the Company is providing a conference call facility. To register for the conference call and receive participant log-in details, please contact the Company at EGM2021@originenterprises.com before 10.30 a.m. on Tuesday, 26 January 2021. Shareholders will not be able to use this facility to vote, ask questions or table resolutions during the meeting.

 

Further Updates

We will continue to closely monitor the evolving situation around the COVID-19 pandemic, including the latest Government and public health guidance, and how this may affect the arrangements for the EGM. Consequently, the arrangements for the EGM are subject to change, possibly at short notice. If it becomes necessary or appropriate to revise the arrangements for the EGM, further information will be announced via a Regulatory Information Service and made available on our website.   

 

If you have any queries, please contact the Company Secretary at EGM2021@originenterprises.com or the Company's Registrar, Link Registrars Limited, on +353-1-553 0050 (9.00am to 5.00pm Monday to Friday, excluding public or bank holidays).

 

 

Barbara Keane

Company Secretary

18 January 2021

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBPMTTMTMBBAB
UK 100

Latest directors dealings